ConditionMalignant Neoplasm of Breast
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age50-90
SponsorInstituto Brasileiro de Controle do Cancer
About this trial
Radiotherapy has been confirmed as an important treatment breast-conserving surgery reducing the risk of any recurrence of breast cancer and breast cancer-related mortality in patients with early breast cancer.
There are no comparative data on the ideal radiotherapy treatment regimen for patients with early stage breast cancer who underwent conservative surgery in the Brazilian population.
Eligibility criteria
Qualifiers
Information to the patient and signed informed consent;
Women aged ≥50 years
Breast conserving surgery
Pathologic tumor size < 3 cm (maximum microscopic diameter of the invasive component)
Disqualifiers
Previous malignancy (except non-melanomatous skin cancer)
Mastectomy
Classical-Type Invasive Lobular Carcinoma
Neoadjuvant chemotherapy
Trial design
Treatments tested in this trial
- Active Comparator: Standard
- Experimental 1: Hypofractionated radiotherapy
- Experimental 2: Accelerated Partial Breast Irradiation
Treatment groups
36 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov